190 related articles for article (PubMed ID: 7663029)
1. Fatal hepatotoxicity following oral administration of amiodarone.
Richer M; Robert S
Ann Pharmacother; 1995 Jun; 29(6):582-6. PubMed ID: 7663029
[TBL] [Abstract][Full Text] [Related]
2. Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports.
Tsuda T; Tada H; Tanaka Y; Nishida N; Yoshida T; Sawada T; Sakata K; Hayashi K; Kawashiri MA; Oyama T; Sasaki M; Kurose N; Yamagishi M
J Med Case Rep; 2018 Apr; 12(1):95. PubMed ID: 29653592
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone hepatotoxicity. A clinicopathologic study of five patients.
Rigas B; Rosenfeld LE; Barwick KW; Enriquez R; Helzberg J; Batsford WP; Josephson ME; Riely CA
Ann Intern Med; 1986 Mar; 104(3):348-51. PubMed ID: 3946978
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure.
Mattar W; Juliar B; Gradus-Pizlo I; Kwo PY
J Gastrointestin Liver Dis; 2009 Dec; 18(4):419-23. PubMed ID: 20076813
[TBL] [Abstract][Full Text] [Related]
5. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature.
Chen CC; Wu CC
Am J Ther; 2016; 23(1):e260-3. PubMed ID: 25259952
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients.
Lewis JH; Ranard RC; Caruso A; Jackson LK; Mullick F; Ishak KG; Seeff LB; Zimmerman HJ
Hepatology; 1989 May; 9(5):679-85. PubMed ID: 2785079
[TBL] [Abstract][Full Text] [Related]
7. Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity.
Giannattasio F; Salvio A; Varriale M; Picciotto FP; Di Costanzo GG; Visconti M
Ann Ital Med Int; 2002; 17(3):180-4. PubMed ID: 12402666
[TBL] [Abstract][Full Text] [Related]
8. [Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].
González Galilea A; García Sánchez MV; la Mata García M; Miño Fugarolas G
Gastroenterol Hepatol; 2002; 25(6):392-4. PubMed ID: 12069701
[TBL] [Abstract][Full Text] [Related]
9. [Amiodarone-induced liver dysfunctions].
Gassanov N; Caglayan E; Erdmann E; Er F
Dtsch Med Wochenschr; 2010 Jul; 135(27):1372-4. PubMed ID: 20589584
[TBL] [Abstract][Full Text] [Related]
10. [The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
López-Gómez D; Nicolás J; Frigola JM; Manito N; Esplugas E
Rev Esp Cardiol; 1999 Mar; 52(3):201-3. PubMed ID: 10193175
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone.
Hashmi A; Keswani NR; Kim S; Graham DY
South Med J; 2016 Feb; 109(2):83-6. PubMed ID: 26840961
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyolysis and hepatotoxicity in a female body builder.
Bates DE; Baylis BW
J Trauma; 2006 Feb; 60(2):407-9; discussion 409. PubMed ID: 16508505
[No Abstract] [Full Text] [Related]
13. How toxic is amiodarone to the liver?
Pollak PT
J Gastrointestin Liver Dis; 2010 Mar; 19(1):11-3. PubMed ID: 20361068
[No Abstract] [Full Text] [Related]
14. Hepatotoxicity of amiodarone.
Jeyamalar R; Pathmanathan R; Wong D; Kannan P
Ann Acad Med Singap; 1992 Nov; 21(6):838-40. PubMed ID: 1295429
[TBL] [Abstract][Full Text] [Related]
15. [Hepatotoxicity caused by glafenin. Apropos of 2 cases].
Caballería Rovíra E; OFFso Ubeda RM; Arago López JV; Sanchís Closa A
Rev Clin Esp; 1992 Jul; 191(3):166-8. PubMed ID: 1354388
[No Abstract] [Full Text] [Related]
16. Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity.
Pollak PT; Sharma AD; Carruthers SG
Am J Cardiol; 1990 May; 65(18):1185-91. PubMed ID: 2337027
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone-induced acute hepatotoxicity.
Rao U; Agarwal A
Eur J Clin Pharmacol; 2012 Apr; 68(4):449-50. PubMed ID: 21989920
[No Abstract] [Full Text] [Related]
18. [Acute hepatotoxicity from amiodarone].
Tosetti C; Ongari M; Evangelisti A; Lolli R; Napoli A
Minerva Med; 1995 Sep; 86(9):387-90. PubMed ID: 7501229
[TBL] [Abstract][Full Text] [Related]
19. Causality assessment of liver injury after chronic oral amiodarone intake.
Llanos L; Moreu R; Peiró AM; Pascual S; Francés R; Such J; Horga JF; Pérez-Mateo M; Zapater P
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):291-300. PubMed ID: 19165760
[TBL] [Abstract][Full Text] [Related]
20. Acute liver injury after intravenous amiodarone: a case report.
Verhovez A; Elia F; Riva A; Ferrari G; Aprà F
Am J Emerg Med; 2011 Sep; 29(7):843.e5-6. PubMed ID: 20870371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]